| Stage | LMT | % of rev | RDN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $20.7B | 100.00% | $628M | 100.00% | LMT ×32.97 |
| Gross profit | $2.4B | 11.76% | $628M | 100.00% | RDN +88.2pp |
| Operating income | $2.4B | 11.80% | $254M | 40.40% | RDN +28.6pp |
| Pre-tax income | $2.2B | 10.49% | $228M | 36.34% | RDN +25.9pp |
| Net income | $1.8B | 8.91% | $164M | 26.05% | RDN +17.1pp |
| Stage | LMT | RDN | Gap · A − B |
|---|---|---|---|
| Revenue | $20.7B100.00% | $628M100.00% | LMT ×32.97 |
| Gross profit | 11.76%$2.4B | 100.00%$628M | RDN +88.2pp |
| Operating income | 11.80%$2.4B | 40.40%$254M | RDN +28.6pp |
| Pre-tax income | 10.49%$2.2B | 36.34%$228M | RDN +25.9pp |
| Net income |
| 8.91%$1.8B |
| 26.05%$164M |
| RDN +17.1pp |
No shared counterparties.